CORC

在结果中检索

CORC

浏览/检索结果: 共184条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文
THORACIC CANCER, 2022
作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo
收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo
收藏  |  浏览/下载：30/0  |  提交时间：2022/12/22
Study of power conversion system for Chinese Fusion Engineering Testing Reactor 期刊论文
ENERGY, 2021, 卷号: 218
作者:  Chen, Zhansheng;  Wan, Teng;  Zhao, Pinghui;  Lei, Mingzhun;  Li, Yuanjie
收藏  |  浏览/下载：25/0  |  提交时间：2021/04/26
Novel two-dimensional tetragonal vanadium carbides and nitrides as promising materials for Li-ion batteries 期刊论文
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2019, 卷号: 21, 期号: 35, 页码: 19513-19520
作者:  Wu, Yi-Yuan;  Bo, Tao;  Zhang, Junrong;  Lu, Zhansheng;  Wang, Zhiguang
收藏  |  浏览/下载：55/0  |  提交时间：2019/11/10
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：55/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
Identification of Abnormal Fucosylated-Glycans Recognized by LTL in Saliva of HBV-Induced Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma. 期刊论文
Glycobiology, 2019, 卷号: 29, 页码: 242-259
作者:  Zhang Jiaxu;  Zhong Yaogang;  Zhang Peixin;  Du Haoqi;  Shu Jian
收藏  |  浏览/下载：12/0  |  提交时间：2019/11/19
Scaling mitigation in membrane distillation: From superhydrophobic to slippery 期刊论文
DESALINATION, 2019, 卷号: 466, 页码: 36-43
作者:  Xiao, Zechun;  Li, Zhansheng;  Guo, Hong;  Liu, Yongjie;  Wang, Yanshai
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace